What this service covers
This service supports weight-loss medication requests and follow-up needs when telemedicine is a safe fit. Medication options may include brand-name treatments such as Wegovy, Zepbound, Foundayo, or Wegovy pill when clinically appropriate. Ozempic and Mounjaro are related GLP-1 medications but are generally diabetes-indicated medications and may not be covered for weight loss unless there is a diabetes-related indication.
- Eligibility and safety assessment
- Medication option discussion when appropriate
- Side-effect and dose-change support
- Follow-up planning and monitoring recommendations
